Announcement of the progress of suspension of major matters of East China Pharmaceutical Co., Ltd.
-
Last Update: 2020-05-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Securities Code: 000963 Securities For short: East China Pharmaceutical Announcement Number: 2014-029 East China Pharmaceutical Co., Ltd the suspension of major matters
progress announcement
the Company and all members of the Board of Directors to ensure that the contents of the information disclosure is true, accurate, complete, there are no false records, misleading statements or major omissions East China Pharmaceutical Co., Ltd (hereinafter referred to as the "Company") due to the relevant company's stock trend
East China Pharmaceutical is planning related major matters, after applying to the Shenzhen Stock Exchange, the company's stock (stock abbreviation: East China Pharma, stock code: 000963) has been suspended from the market on June 3, 2014 (Tuesday), the Company issued a "major matters suspension notice" on June 3, 2014, the announcement number is 2014-027 On June 9, 2014, the Company issued the Notice of progress of the suspension of major
matters, with the proclamation number 2014-028, and the company's shares continued to be suspended from the opening of the market on June 10, 2014 at present, the company and related parties are actively promoting the relevant work, the company's board of directors has been on the relevant matters to demonstrate and communicate, in order to protect the interests of the vast number of investors, to avoid abnormal fluctuations in the company's stock prices, according to relevant regulations, the company's shares will continue to be suspended from the opening of the market on June 17, 2014, the company plans to be in accordance with the relevant requirements by Friday, June 20, 2014 and re-branded during the suspension of the , the Company will fulfill its obligations of information disclosure in a timely manner in accordance with the relevant laws and regulations in accordance with the progress of the matter Investors are kindly requested to be aware of the risks this announcement East China Pharmaceutical Co., Ltd Board of Directors June 16, 2014 source Shanghai Securities News) click to enter the "Share Friends" to participate in the discussion
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
